Citius Oncology, Inc. (CTOR) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 1.67M | 3.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 328.88K | 789.21K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 19.73% | 20.01% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 1.34M | 3.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 80.27% | 79.99% | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 29.95M | 8.41M | 4.71M | 4.94M | 7.47M | 6.39M | 6.67M | 4.63M | 4.69M | 4.58M | 5.04M | 138.12K |
| OpEx % of Revenue | 1796.44% | 213.16% | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 27.15M | 6.82M | 3.64M | 4.01M | 4.33M | 5.13M | 5.37M | 3.5M | 3.34M | 3.43M | 3.89M | 774.15K |
| SG&A % of Revenue | 1628.52% | 172.8% | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 2.8M | 1.02M | 1.08M | 938.28K | 3.14M | 1.26M | 1.3M | 1.13M | 1.35M | 1.15M | 1.15M | 934.28K |
| R&D % of Revenue | 167.92% | 25.82% | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 573.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Operating Income | -28.61M | -5.25M | -4.71M | -4.94M | -7.47M | -6.39M | -6.67M | -4.63M | -4.69M | -4.58M | -5.04M | -138.12K |
| Operating Margin % | -1716.17% | -133.17% | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -282.98% | 17.87% | 29.35% | -6.83% | -59.25% | -39.52% | -32.22% | - | - | - | - | - |
| EBITDA | -28.61M | -4.68M | -4.68M | -4.94M | -7.47M | -6.39M | -6.67M | -4.63M | -4.69M | -4.58M | 0 | 380.81K |
| EBITDA Margin % | -1716.17% | -118.63% | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -282.98% | 26.84% | 29.9% | -6.83% | -59.25% | -39.52% | - | - | - | - | - | - |
| D&A (Non-Cash Add-back) | 0 | 573.44K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.04M | 0 |
| EBIT | -28.61M | -5.22M | -4.68M | -4.94M | -7.47M | -6.39M | -6.67M | -4.63M | -4.69M | -4.58M | -5.04M | 380.81K |
| Net Interest Income | 10.69K | -17.55K | -57.28K | -160.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 493.02K |
| Interest Income | 43.72K | 28.29K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 493.02K |
| Interest Expense | 33.03K | 45.84K | 57.28K | 160.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 1.77M | -17.55K | -20.9K | -160.75K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 518.93K |
| Pretax Income | -26.84M | -5.27M | -4.73M | -5.11M | -7.47M | -6.39M | -6.67M | -4.63M | -4.69M | -4.58M | -5.04M | 380.81K |
| Pretax Margin % | -1609.84% | -133.61% | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -231.21K | 264.24K | 264.24K | 264.24K | 264.24K | 264.24K | 144K | 144K | 144K | 144K | 144K | 1.85K |
| Effective Tax Rate % | 0.86% | -5.01% | -5.58% | -5.18% | -3.54% | -4.13% | -2.16% | -3.11% | -3.07% | -3.14% | -2.86% | 0.49% |
| Net Income | -26.61M | -5.53M | -5M | -5.37M | -7.74M | -6.66M | -6.81M | -4.77M | -4.84M | -4.73M | -5.19M | 380.81K |
| Net Margin % | -1595.98% | -140.31% | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -243.99% | 16.9% | 26.66% | -12.51% | -59.97% | -40.86% | -31.33% | - | - | - | - | - |
| Net Income (Continuing) | -26.61M | -5.53M | -5M | -5.37M | -7.74M | -6.66M | -6.81M | -4.77M | -4.84M | -4.73M | -5.19M | -1.85K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.27 | -0.06 | -0.06 | -0.08 | -0.11 | -0.09 | -0.10 | -0.07 | -0.07 | -0.06 | -0.37 | 0.04 |
| EPS Growth % | -145.45% | 32.01% | 36.85% | -6.08% | -53.63% | -55.17% | 73.48% | - | - | - | - | - |
| EPS (Basic) | -0.27 | -0.06 | -0.06 | -0.08 | -0.11 | -0.09 | -0.10 | -0.07 | -0.07 | -0.06 | -0.37 | 0.04 |
| Diluted Shares Outstanding | 100.03M | 87.46M | 80.94M | 71.55M | 71.55M | 71.55M | 71.55M | 66.53M | 66.53M | 89.41M | 89.48M | 90.16M |
| Basic Shares Outstanding | 100.03M | 87.46M | 80.94M | 71.55M | 71.55M | 71.55M | 71.55M | 66.53M | 66.53M | 89.41M | 89.48M | 90.16M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |